Urine alpha1-Microglobulin (Urine A1M) levels in HIV infected men and HIV uninfected men and Urine A1M as biomarker for detecting and monitoring Tenofovir disoproxil fumarate (TDF)-associated tubular toxicity: A Cross-sectional Analysis in the Multicenter AIDS Cohort Study

Trial Profile

Urine alpha1-Microglobulin (Urine A1M) levels in HIV infected men and HIV uninfected men and Urine A1M as biomarker for detecting and monitoring Tenofovir disoproxil fumarate (TDF)-associated tubular toxicity: A Cross-sectional Analysis in the Multicenter AIDS Cohort Study

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Jun 2017

At a glance

  • Drugs Tenofovir disoproxil fumarate (Primary)
  • Indications HIV infections
  • Focus Biomarker; Pharmacodynamics
  • Acronyms AIDS Cohort Study
  • Most Recent Events

    • 16 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top